Details for Patent: 8,962,028
✉ Email this page to a colleague
Which drugs does patent 8,962,028 protect, and when does it expire?
Patent 8,962,028 protects ULTRAVATE and is included in one NDA.
This patent has twenty-two patent family members in eighteen countries.
Summary for Patent: 8,962,028
| Title: | Topical steroid composition and method |
| Abstract: | Storage stable, topical lotion compositions for treating corticosteroid-responsive dermatoses are provided by the present invention which include a halobetasol material comprising halobetasol or its pharmaceutically acceptable salts, esters, and solvates; and a pharmaceutically acceptable carrier which includes: (a) one or more fatty alcohols and/or one or more alkoxylated fatty alcohols, (b) one or more polyol humectants, and (c) diisopropyl adipate. Storage stable, topical lotion compositions for treating corticosteroid-responsive dermatoses are provided by the present invention which include 0.05% halobetasol propionate; and a pharmaceutically acceptable carrier which includes: (a) one or more fatty alcohols and/or one or more alkoxylated fatty alcohols, (b) one or more polyol humectants, and (c) diisopropyl adipate. |
| Inventor(s): | Johnson; Keith A. (Durham, NC), Popp; Karl F. (Schodack Landing, NY) |
| Assignee: | MiCal Pharmaceuticals LLC--H Series, a Series of MiCal Pharmaceuticals LLC, a Multi-Division Limited Liability Company (San Diego, CA) |
| Application Number: | 13/921,833 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,962,028 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Delivery; Formulation; Device; |
Drugs Protected by US Patent 8,962,028
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Industries | ULTRAVATE | halobetasol propionate | LOTION;TOPICAL | 208183-001 | Nov 6, 2015 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | USE OF A LOTION CONTAINING HALOBETASOL PROPIONATE FOR THE TREATMENT OF CORTICOSTEROID-RESPONSIVE DERMATOSES INCLUDING PSORIASIS | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,962,028
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2013331271 | ⤷ Try a Trial | |||
| Brazil | 112015008951 | ⤷ Try a Trial | |||
| Canada | 2888853 | ⤷ Try a Trial | |||
| China | 104884043 | ⤷ Try a Trial | |||
| Eurasian Patent Organization | 029494 | ⤷ Try a Trial | |||
| Eurasian Patent Organization | 201590730 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
